Stevens & Bolton has advised Philips on the sale of its Belfast-based Digital and Computational Pathology business, formerly known as PathXL, to medical informatics and image technology company, Cirdan.
PathXL was founded in 2004 as a Queen’s University Belfast spin out company and was purchased by Philips in 2016. It offers a range of digital pathology software applications for research and education addressing growing segments of the pathology market including bio-pharma.
The Stevens & Bolton team was led by corporate partner Keith Syson, supported by Nassar Nassar (corporate), Kate Schmit (corporate tax) and Kerry Garcia (employment).
Keith Syson